Table 3 Vaccination coverage ascertained by vaccination card or medical records among 641 surveyed children aged 12–71 months (weighted), by birth cohort, Bolivar, Venezuela, 2011

BCG (birth)

123

(95)

[89–98]

126

(96)

[91–98]

139

(99)

[94- > 99]

136

(98)

[93–99]

99

(98)

[93–99]

Hepatitis B* (birth)

112

(87)

[81–91]

106

(81)

[71–88]

131

(93)

[86–97]

127

(92)

[83–96]

86

(85)

[77–91]

Penta3* (6 months)

117

(91)

[85–94]

121

(92)

[86–96]

127

(90)

[83–94]

137

(99)

[94- >99]

93

(92)

[85–96]

OPV3 (6 months)

111

(86)

[78–91]

121

(92)

[86–96]

126

(89)

[82–94]

133

(96)

[91–98]

93

(92)

[81–97]

MMR1* (12 months)

94

(72)

[63–80]

116

(89)

[81–94]

128

(91)

[79–96]

129

(93)

[85–97]

89

(88)

[77–94]

Yellow fever* (12 months)

81

(62)

[54–70]

107

(82)

[75–87]

130

(92)

[86–96]

132

(95)

[88–98]

94

(93)

[87–97]

Rotavirus2* (4–8 months)

67

(51)

[41–62]

68

(52)

[43–60]

53

(38)

[28–48]

38

(27)

[19–36]

21

(21)

[14–29]

DTP booster1* (18 months)

N/A

N/A

N/A

33

(59)

[52–66]

87

(61)

[48–73]

103

(74)

[62–83]

78

(77)

[67–85]

OPV booster1* (18 months)

N/A

N/A

N/A

84

(64)

[55–72]

91

(64)

[57–75]

113

(81)

[69–90]

80

(79)

[66–88]

DTP booster2 (5 years)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

17

(17)

[10–27]

OPV booster2 (5 years)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

34

(34)

[22–47]

MMR2 (5 years)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

27

(27)

[18–37]